William E. Rote - Jan 24, 2022 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Senior Vice President, R&D
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Jan 24, 2022
Transactions value $
-$46,838
Form type
4
Date filed
1/26/2022, 03:37 PM
Previous filing
Jan 12, 2022
Next filing
Feb 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$46.8K -1.88K -4.88% $24.98 36.5K Jan 24, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.